SCHEMBL523312

SCHEMBL523312

CCCCCCCCCCCCCCCCCC(O)(O)O

nearest known ligand 0.52

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
FDPS P14324 9/20 0.52
GGPS1 O95749 7/20 0.52
TSHR P16473 1/20 0.50
THRB P10828 1/20 0.50
SMPD1 P17405 1/20 0.46
LMNA P02545 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL668973 1.00 FDPS (0.52) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL10777189 1.00 FDPS (0.52) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL2351980 1.00 FDPS (0.52) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL2351557 1.00 FDPS (0.52) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL4897958 1.00 FDPS (0.52) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL312713 1.00 FDPS (0.52) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL4898007 1.00 FDPS (0.52) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL9062203 1.00 FDPS (0.52) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL2354987 1.00 FDPS (0.52) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL9062205 1.00 FDPS (0.52) FDPSGGPS1TSHRTHRBSMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117736444-A Polyether amine for surfactant and preparation method thereof 淮安晨化新材料有限公司 2024-03-22 CN claimed
EP-2385980-A1 BACTERIAL VACCINES WITH CELL WALL-ASSOCIATED CERAMIDE-LIKE GLYCOLIPIDS AND USES THEREOF The Albert Einstein College Of Medicine Of Yeshiva University (US) 2011-11-16 EP claimed
US-8040452-B2 Manufacturing method for a thin film transistor-liquid crystal display having an insulating layer exposing portions of a gate island BEIJING BOE OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) 2011-10-18 US claimed
WO-2010081026-A1 BACTERIAL VACCINES WITH CELL WALL-ASSOCIATED CERAMIDE-LIKE GLYCOLIPIDS AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY, A DIVISION OF YESHIVA UNIVERSITY (US) 2010-07-15 WO claimed
EP-0804280-B1 EMULSIFYING AGENTS COGNIS IP MAN GMBH (DE) 2007-03-21 EP claimed
US-12629421-B2 Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) 2026-05-19 US disclosed
US-12280114-B2 Extraction of plant source “medicinal soup” and manual preparation of “herbal medicine” and related products INSTITUTE OF BASIC MEDICAL SCIENCES (CN) 2025-04-22 US disclosed
CN-119463144-A Self-nucleation modified polylactic acid and preparation method thereof 浙江海正生物材料股份有限公司 2025-02-18 CN disclosed
US-20250041423-A1 EXTRACTION OF PLANT SOURCE \"MEDICINAL SOUP\" AND MANUAL PREPARATION OF \"HERBAL MEDICINE\" AND RELATED PRODUCTS BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) 2025-02-06 US disclosed
WO-2024260330-A1 AN EMULSION COMPOSITION COMPRISING POLYGLYCERYL ESTER AND ALKYL GLYCOSIDE BASF SE (DE) 2024-12-26 WO disclosed
CN-118973539-A Process for preparing shelf stable sulfur-containing personal care compositions 宝洁公司 2024-11-15 CN disclosed
WO-2024231079-A1 HYDRATABLE CONCENTRATE CLEANSING COMPOSITIONS UNILEVER IP HOLDINGS B.V. (NL) 2024-11-14 WO disclosed
EP-1265619-A1 COMPOSITION BASED ON SPHINGOLIPID AND BETA-HYDROXY-ACID FOR SKIN CARE Laboratoire D'Evolution Dermatologique (L.E.D.) (FR) 2002-12-18 EP disclosed
WO-2002072684-A1 CHLORATE-CONTAINING STABILIZER SYSTEM WITH NITROGEN-CONTAINING SYNERGISTS FOR STABILIZING HALOGEN-CONTAINING POLYMERS CROMPTON VINYL ADDITIVES GMBH (DE) 2002-09-19 WO disclosed
WO-2001070235-A1 COMPOSITION BASED ON SPHINGOLIPID AND BETA-HYDROXY-ACID FOR SKIN CARE LABORATOIRE D'EVOLUTION DERMATOLOGIQUE (L.E.D.) (FR) 2001-09-27 WO disclosed
US-5795978-A CONTAINING ALKYL OR ALKENL OLIGOGLYCOSIDE AND FATTY ALCOHOL;COSMETICS, DRUGS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1998-08-18 US disclosed
EP-0804280-A1 EMULSIFYING AGENTS Henkel Kommanditgesellschaft auf Aktien (DE) 1997-11-05 EP disclosed
WO-1997018033-A1 EMULSIFYING AGENTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1997-05-22 WO disclosed
US-5512198-A WEAR RESISTANCE NIPPON OIL CO., LTD. (JP) 1996-04-30 US disclosed
EP-0582451-A1 Refrigerator oil composition for fluoroalkane refrigerant NIPPON OIL CO. LTD. (JP) 1994-02-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12280114-B2 Extraction of plant source “medicinal soup” and manual preparation of “herbal medicine” and related products CHMP4B, FIP1L1, LIPC FDPS 404/4885GGPS1 468/4885TSHR 4574/4885
US-12629421-B2 Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid S1PR2, S1PR3, S1PR1 FDPS 2366/4885GGPS1 266/4885TSHR 1192/4885
US-20250041423-A1 EXTRACTION OF PLANT SOURCE \"MEDICINAL SOUP\" AND MANUAL PREPARATION OF \"HERBAL MEDICINE\" AND RELATED PRODUCTS CHMP4B, EXOSC5, FIP1L1 FDPS 322/4885GGPS1 239/4885TSHR 4534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.